title: Disseminated intravascular coagulation and immune hemolytic anemia, possibly Evans syndrome, after oxaliplatin and bevacizumab infusion for metastatic colon adenocarcinoma: a case report and literature review.
authors.affiliation: Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA.
authors.forename: Lingjin
authors.initials: L
authors.lastname: Meng
authors.affiliation: Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA; Division of Hematology and Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA.
authors.forename: Andrew
authors.initials: A
authors.lastname: Romano
authors.affiliation: Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA; Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA.
authors.forename: Elliot
authors.initials: E
authors.lastname: Smith
authors.affiliation: Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA; Division of Hematology and Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA.
authors.forename: Gail
authors.initials: G
authors.lastname: Macik
authors.affiliation: Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA; Division of Hematology and Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA. Electronic address: wwg9u@hscmail.mcc.virginia.edu.
authors.forename: William W
authors.initials: WW
authors.lastname: Grosh
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D000068258:Bevacizumab; D003110:Colonic Neoplasms / Q000188:drug therapy; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D000068258:Bevacizumab
keywords: Coagulopathy; Drug toxicity; Hematuria; Metastatic colonic carcinoma; Renal injury; Thrombotic microangiopathy